Literature DB >> 26392405

Inflammation, Depression, and Slow Gait: A High Mortality Phenotype in Later Life.

Patrick J Brown1, Steven P Roose2, Jun Zhang3, Melanie Wall3, Bret R Rutherford2, Hilsa N Ayonayon4, Meryl A Butters5, Tamara Harris6, Anne B Newman7, Suzanne Satterfield8, Eleanor M Simonsick9, Kristine Yaffe10.   

Abstract

BACKGROUND: Inflammation, slow gait, and depression individually are associated with mortality, yet little is known about the trajectories of these measures, their interrelationships, or their collective impact on mortality.
METHODS: Longitudinal latent class analysis was used to evaluate trajectories of depression (Center for Epidemiologic Studies Depression ≥ 10), slow gait (<1.0 m/s), and elevated inflammation (interleukin 6 > 3.2 pg/mL) using data from the Health Aging and Body Composition Study. Logistic regression was used to identify their associations with mortality.
RESULTS: For each outcome, low-probability (n inflammation = 1,656, n slow gait = 1,471, n depression = 1,458), increasing-probability (n inflammation = 847, n slow gait = 880, n depression = 1,062), and consistently high-probability (n inflammation = 572, n slow gait = 724, n depression = 555) trajectories were identified, with 22% of all participants classified as having increasing or consistently high-probability trajectories on inflammation, slow gait, and depression (meaning probability of impairment on each outcome increased from low to moderate/high or remained high over 10 years). Trajectories of slow gait were associated with inflammation (r = .40, p < .001) and depression (r = .49, p < .001). Although worsening trajectories of inflammation were independently associated with mortality (p < .001), the association between worsening trajectories of slow gait and mortality was only present in participants with worsening depression trajectories (p < .01). Participants with increasing/consistently high trajectories of depression and consistently high trajectories of inflammation and slow gait (n = 247) have an adjusted-morality rate of 85.2%, greater than all other classification permutations.
CONCLUSIONS: Comprehensive assessment of older adults is warranted for the development of treatment strategies targeting a high-mortality risk phenotype consisting of inflammation, depression, and slow gait speed.
© The Author 2015. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Depression; Frailty; Inflammation; Mortality; Slow Gait

Mesh:

Substances:

Year:  2015        PMID: 26392405      PMCID: PMC4723663          DOI: 10.1093/gerona/glv156

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  42 in total

1.  Gait characteristics of elderly people with a history of falls: a dynamic approach.

Authors:  Yaron Barak; Robert C Wagenaar; Kenneth G Holt
Journal:  Phys Ther       Date:  2006-11

2.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

3.  Relationship of clinic-based gait speed measurement to limitations in community-based activities in older adults.

Authors:  Joe Verghese; Cuiling Wang; Roee Holtzer
Journal:  Arch Phys Med Rehabil       Date:  2011-05       Impact factor: 3.966

Review 4.  Psychosocial interventions for the prevention of depression in older adults: systematic review and meta-analysis.

Authors:  Anna K Forsman; Isabell Schierenbeck; Kristian Wahlbeck
Journal:  J Aging Health       Date:  2010-10-08

5.  Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: Preliminary findings.

Authors:  Ebrahim Haroon; Jennifer C Felger; Bobbi J Woolwine; Xiangchuan Chen; Samir Parekh; James R Spivey; Xiaoping P Hu; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2014-12-09       Impact factor: 7.217

6.  Trajectories of inflammatory markers and cognitive decline over 10 years.

Authors:  Andrea L Metti; Kristine Yaffe; Robert M Boudreau; Eleanor M Simonsick; Ryan M Carnahan; Suzanne Satterfield; Tamara B Harris; Hilsa N Ayonayon; Caterina Rosano; Jane A Cauley
Journal:  Neurobiol Aging       Date:  2014-06-06       Impact factor: 4.673

7.  A novel aging phenotype of slow gait, impaired executive function, and depressive symptoms: relationship to blood pressure and other cardiovascular risks.

Authors:  Ihab Hajjar; Frances Yang; Farzaneh Sorond; Richard N Jones; William Milberg; L Adrienne Cupples; Lewis A Lipsitz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-06-17       Impact factor: 6.053

8.  Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study).

Authors:  Matteo Cesari; Brenda W J H Penninx; Anne B Newman; Stephen B Kritchevsky; Barbara J Nicklas; Kim Sutton-Tyrrell; Russell P Tracy; Susan M Rubin; Tamara B Harris; Marco Pahor
Journal:  Am J Cardiol       Date:  2003-09-01       Impact factor: 2.778

Review 9.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

Authors:  Claudio Franceschi; Judith Campisi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-06       Impact factor: 6.053

10.  Patterns of circulating inflammatory biomarkers in older persons with varying levels of physical performance: a partial least squares-discriminant analysis approach.

Authors:  Emanuele Marzetti; Francesco Landi; Federico Marini; Matteo Cesari; Thomas W Buford; Todd M Manini; Graziano Onder; Marco Pahor; Roberto Bernabei; Christiaan Leeuwenburgh; Riccardo Calvani
Journal:  Front Med (Lausanne)       Date:  2014-09-01
View more
  21 in total

1.  Biological Age, Not Chronological Age, Is Associated with Late-Life Depression.

Authors:  Patrick J Brown; Melanie M Wall; Chen Chen; Morgan E Levine; Kristine Yaffe; Steven P Roose; Bret R Rutherford
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-09-11       Impact factor: 6.053

2.  Effects of L-DOPA Monotherapy on Psychomotor Speed and [11C]Raclopride Binding in High-Risk Older Adults With Depression.

Authors:  Bret R Rutherford; Mark Slifstein; Chen Chen; Anissa Abi-Dargham; Patrick J Brown; Melanie W Wall; Nora Vanegas-Arroyave; Yaakov Stern; Veronika Bailey; Emily Valente; Steven P Roose
Journal:  Biol Psychiatry       Date:  2019-04-15       Impact factor: 13.382

3.  Declining Skeletal Muscle Mitochondrial Function Associated With Increased Risk of Depression in Later Life.

Authors:  Patrick J Brown; Nicholas Brennan; Adam Ciarleglio; Chen Chen; Carolina Montes Garcia; Stephanie Gomez; Steven P Roose; Bret R Rutherford; Eleanor M Simonsick; Richard G Spencer; Luigi Ferrucci
Journal:  Am J Geriatr Psychiatry       Date:  2019-04-06       Impact factor: 4.105

4.  Factors Associated With Ischemic Stroke Survival and Recovery in Older Adults.

Authors:  Divya Thekkethala Winovich; William T Longstreth; Alice M Arnold; Ravi Varadhan; Adina Zeki Al Hazzouri; Mary Cushman; Anne B Newman; Michelle C Odden
Journal:  Stroke       Date:  2017-05-19       Impact factor: 7.914

5.  Older Adults' Perspectives on Clinical Research: A Focus Group and Survey Study.

Authors:  Eric J Lenze; Alex Ramsey; Patrick J Brown; Charles F Reynolds; Benoit H Mulsant; Helen Lavretsky; Steven P Roose
Journal:  Am J Geriatr Psychiatry       Date:  2016-07-29       Impact factor: 4.105

6.  Frailty and Its Correlates in Adults With Late Life Depression.

Authors:  Patrick J Brown; Steven P Roose; Kaleigh R O'Boyle; Adam Ciarleglio; Benjamin Maas; Kay C Igwe; Sarah Chung; Stephanie Gomez; Maleeha Naqvi; Adam M Brickman; Bret R Rutherford
Journal:  Am J Geriatr Psychiatry       Date:  2019-10-14       Impact factor: 4.105

7.  Longitudinal Association between Late-Life Depression (LLD) and Frailty: Findings from a Prospective Cohort Study (MiMiCS-FRAIL).

Authors:  M K Borges; C V Romanini; N A Lima; M Petrella; D L da Costa; V N An; B N Aguirre; J R Galdeano; I C Fernandes; J F Cecato; E C Robello; R C Oude Voshaar; I Aprahamian
Journal:  J Nutr Health Aging       Date:  2021       Impact factor: 4.075

8.  Neuroanatomical predictors of L-DOPA response in older adults with psychomotor slowing and depression: A pilot study.

Authors:  Bret R Rutherford; Jongwoo Choi; Mark Slifstein; Kaleigh O'Boyle; Anissa Abi-Dargham; Patrick J Brown; Melanie W Wall; Nora Vanegas-Arroyave; Jayant Sakhardande; Yaakov Stern; Steven P Roose
Journal:  J Affect Disord       Date:  2020-01-15       Impact factor: 4.839

Review 9.  The Depressed Frail Phenotype: The Clinical Manifestation of Increased Biological Aging.

Authors:  Patrick J Brown; Bret R Rutherford; Kristine Yaffe; Jane M Tandler; Justina Laurence Ray; Emily Pott; Sarah Chung; Steven P Roose
Journal:  Am J Geriatr Psychiatry       Date:  2016-06-23       Impact factor: 4.105

10.  Frailty Worsens Antidepressant Treatment Outcomes in Late Life Depression.

Authors:  Patrick J Brown; Adam Ciarleglio; Steven P Roose; Carolina Montes Garcia; Sarah Chung; Johana Alvarez; Alexandra Stein; Stephanie Gomez; Bret R Rutherford
Journal:  Am J Geriatr Psychiatry       Date:  2020-12-25       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.